Global DNA methylation in a population with aflatoxin B1 exposure

Epigenetics

Volumn 8, Issue 9, 2013, Pages 962-969

  Wu, Hui Chen ^a   Wang, Qiao ^a   Yang, Hwai I ^b,c   Tsai, Wei Yann ^a,d   Chen, Chien Jen ^e,f   Santella, Regina M ^a,g  

^a Columbia University ^*  (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g NewYork Presbyterian Hospital   (United States)

Author keywords

DNA methylation; Global DNA methylation; Hepatitis B virus; LINE 1; Sat2; White blood cell

Indexed keywords

AFLATOXIN B1; ALBUMIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; GENE; HUMAN; HUMAN CELL; LINE 1 GENE; MALE; PYROSEQUENCING; SAT2 GENE; SMOKING; URINALYSIS;

HEPATITIS B VIRUS;

AFLATOXIN B1; DNA METHYLATION; GLOBAL DNA METHYLATION; HEPATITIS B VIRUS; LINE-1; SAT2; WHITE BLOOD CELL;

ACETYLTRANSFERASES; ADULT; AFLATOXIN B1; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENOME, HUMAN; HUMANS; LEUKOCYTES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883499108     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.25696     Document Type: Article

References (63)

1. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350:429-31; PMID:1672732; http://dx.doi.org/10.1038/350429a0
2. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350:427-8; PMID:1849234; http://dx.doi.org/10.1038/350427a0
3. Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, et al. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res 1997; 57:3471-7; PMID:9270015
4. Forrester LM, Neal GE, Judah DJ, Glancey MJ, Wolf CR. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proc Natl Acad Sci U S A 1990; 87:8306-10; PMID:2122459; http://dx.doi.org/10.1073/ pnas.87.21.8306
5. Essigmann JM, Croy RG, Nadzan AM, Busby WF Jr., Reinhold VN, Büchi G, et al. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A 1977; 74:1870-4; PMID:266709; http://dx.doi.org/10.1073/ pnas.74.5.1870
6. Gallagher EP, Wienkers LC, Stapleton PL, Kunze KL, Eaton DL. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Res 1994; 54:101-8; PMID:8261428
7. Sabbioni G, Skipper PL, Büchi G, Tannenbaum SR. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis 1987; 8:819-24; PMID:3111739; http://dx.doi.org/10.1093/carcin/8.6.819
8. Wu HC, Santella R. The role of aflatoxins in hepatocellular carcinoma. Hepat Mon 2012; 12(10 HCC):e7238; PMID:23162603; http://dx.doi. org/10.5812/hepatmon.7238
9. Wang LY, Hatch MC, Chen CJ, Levin B, You SL, Lu SN, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996; 67:620-5; PMID:8782648; http://dx.doi.org/10.1002/ (SICI)1097-0215(19960904)67:5<620::AIDIJC5> 3.0.CO;2-W
10. Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Zhang YJ, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996; 24:38-42; PMID:8707279; http://dx.doi.org/10.1002/ hep.510240108
11. Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 1999; 30:379-83; PMID:10421643; http://dx.doi.org/10.1002/hep.510300204
12. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, et al. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev 2009; 18:846-53; PMID:19273485; http://dx.doi.org/10.1158/1055-9965.EPI-08-0697
13. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339:943-6; PMID:1348796; http://dx.doi.org/10.1016/0140-6736(92)91528-G
14. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3:3-10; PMID:8118382
15. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996; 59:128-34; PMID:8659516
16. Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 1997; 27:320-30; PMID:9288607; http://dx.doi. org/10.1016/S0168-8278(97)80178-X
17. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28; PMID:12042769
18. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21:5400-13; PMID:12154403; http://dx.doi.org/10.1038/ sj.onc.1205651
19. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al.; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921; PMID:11237011; http://dx.doi. org/10.1038/35057062
20. Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibriya MG, et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012; 55:1799-808; PMID:22234943; http://dx.doi.org/10.1002/ hep.25569
21. Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol Carcinog 2002; 35:85-92; PMID:12325038; http://dx.doi.org/10.1002/ mc.10076
22. Zhang YJ, Rossner P Jr., Chen Y, Agrawal M, Wang Q, Wang L, et al. Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients. Int J Cancer 2006; 119:985-91; PMID:16570275; http://dx.doi.org/10.1002/ ijc.21699
23. Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen SY, Lee PH, et al. Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 2005; 221:135-43; PMID:15808399; http://dx.doi.org/10.1016/j.canlet. 2004.08.028
24. Zhang YJ, Chen Y, Ahsan H, Lunn RM, Lee PH, Chen CJ, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma. Int J Cancer 2003; 103:440-4; PMID:12478658; http://dx.doi.org/10.1002/ ijc.10852
25. Shen J, Wang S, Zhang YJ, Wu HC, Kibriya MG, Jasmine F, et al. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics 2013; 8:34-43; PMID:23208076; http:// dx.doi.org/10.4161/epi.23062
26. Lambert MP, Paliwal A, Vaissière T, Chemin I, Zoulim F, Tommasino M, et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 2011; 54:705-15; PMID:21146512; http:// dx.doi.org/10.1016/j.jhep.2010.07.027
27. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV, et al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One 2010; 5:e9749; PMID:20305825; http:// dx.doi.org/10.1371/journal.pone.0009749
28. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775:138-62; PMID:17045745
29. Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM. Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis 2012; 33:1340-5; PMID:22581841; http://dx.doi. org/10.1093/carcin/bgs160
30. Bailey EA, Iyer RS, Stone MP, Harris TM, Essigmann JM. Mutational properties of the primary aflatoxin B1-DNA adduct. Proc Natl Acad Sci U S A 1996; 93:1535-9; PMID:8643667; http://dx.doi. org/10.1073/pnas.93.4.1535
31. Shen HM, Ong CN, Lee BL, Shi CY. Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 1995; 16:419-22; PMID:7859375; http://dx.doi.org/10.1093/carcin/ 16.2.419
32. Shen HM, Shi CY, Shen Y, Ong CN. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic Biol Med 1996; 21:139-46; PMID:8818628; http://dx.doi. org/10.1016/0891-5849(96)00019-6
33. Wu HC, Wang Q, Wang LW, Yang HI, Ahsan H, Tsai WY, et al. Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 2007; 28:995-9; PMID:17127712; http://dx.doi. org/10.1093/carcin/bgl234
34. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, et al. Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 2008; 29:971-6; PMID:18310087; http://dx.doi. org/10.1093/carcin/bgn057
35. Turk PW, Laayoun A, Smith SS, Weitzman SA. DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995; 16:1253-5; PMID:7767994; http://dx.doi.org/10.1093/carcin/16.5.1253
36. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004; 32:4100-8; PMID:15302911; http://dx.doi.org/10.1093/nar/ gkh739
37. Pogribny IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor α. Mutat Res 2007; 625:62-71; PMID:17586532; http://dx.doi.org/10.1016/j.mrfmmm. 2007.05.004
38. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92; PMID:17320506; http://dx.doi. org/10.1016/j.cell.2007.01.029
39. Lahiri DK. An integrated approach to genome studies. Science 2011; 331:147; PMID:21233370; http:// dx.doi.org/10.1126/science.331.6014.147-a
40. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002; 132(Suppl):2393S-400S; PMID:12163699
41. Jousse C, Parry L, Lambert-Langlais S, Maurin AC, Averous J, Bruhat A, et al. Perinatal undernutrition affects the methylation and expression of the leptin gene in adults: implication for the understanding of metabolic syndrome. FASEB J 2011; 25:3271-8; PMID:21670064; http://dx.doi.org/10.1096/fj.11-181792
42. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, et al. DNA methylation differences after exposure to prenatal famine are common and timingand sex-specific. Hum Mol Genet 2009; 18:4046-53; PMID:19656776; http://dx.doi.org/10.1093/hmg/ ddp353
43. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008; 105:17046-9; PMID:18955703; http://dx.doi.org/10.1073/ pnas.0806560105
44. Arasaradnam RP, Commane DM, Bradburn D, Mathers JC. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 2008; 3:193-8; PMID:18682688; http:// dx.doi.org/10.4161/epi.3.4.6508
45. Mathers JC. Pulses and carcinogenesis: potential for the prevention of colon, breast and other cancers. Br J Nutr 2002; 88(Suppl 3):S273-9; PMID:12498627; http:// dx.doi.org/10.1079/BJN2002717
46. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst 2002; 94:755-61; PMID:12011226; http://dx.doi.org/10.1093/jnci/94.10.755
47. Feng Y, Xue W, Li P, et al. RASSF1A Hypermethylation is Associated with Aflatioxin B1 and Polycyclic Aromatic Hydrocarbon Exposure in Hepatocellular Carcinoma. Hepatogastroenterology 2011; 59:118-9
48. Vivekanandan P, Daniel HDJ, Kannangai R, Martinez-Murillo F, Torbenson M, Hepatitis B. Hepatitis B virus replication induces methylation of both host and viral DNA. J Virol 2010; 84:4321-9; PMID:20147412; http://dx.doi.org/10.1128/JVI.02280-09
49. Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 2010; 78(Suppl 1):172-9; PMID:20616601; http://dx.doi. org/10.1159/000315247
50. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011; 6:828-37; PMID:21636973; http:// dx.doi.org/10.4161/epi.6.7.16500
51. Makarananda K, Pengpan U, Srisakulthong M, Yoovathaworn K, Sriwatanakul K. Monitoring of aflatoxin exposure by biomarkers. J Toxicol Sci 1998; 23(Suppl 2):155-9; PMID:9760454; http://dx.doi. org/10.2131/jts.23.SupplementII_155
52. Scholl PF, Groopman JD. Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence. Cancer Epidemiol Biomarkers Prev 2008; 17:1436-9; PMID:18559559; http://dx.doi.org/10.1158/1055-9965.EPI-07-2926
53. Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, Wogan GN, et al. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis 1988; 9:1323-5; PMID:3133131; http://dx.doi.org/10.1093/ carcin/9.7.1323
54. Zhu JQ, Zhang LS, Hu X, Xiao Y, Chen JS, Xu YC, et al. Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine. Cancer Res 1987; 47:1848-52; PMID:3102051
55. Ahsan H, Wang LY, Chen CJ, Tsai WY, Santella RM. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype. Environ Health Perspect 2001; 109:833-7; PMID:11564620; http:// dx.doi.org/10.1289/ehp.01109833
56. Wu HC, Wang Q, Delgado-Cruzata L, Santella RM, Terry MB. Genomic methylation changes over time in peripheral blood mononuclear cell DNA: differences by assay type and baseline values. Cancer Epidemiol Biomarkers Prev 2012; 21:1314-8; PMID:22665578; http://dx.doi.org/10.1158/1055-9965.EPI-12-0300
57. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7:e41361; PMID:22848472; http://dx.doi. org/10.1371/journal.pone.0041361
58. Deaton AM, Webb S, Kerr ARW, Illingworth RS, Guy J, Andrews R, et al. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res 2011; 21:1074-86; PMID:21628449; http://dx.doi.org/10.1101/gr.118703.110
59. Wu HC, Delgado-Cruzata L, Flom JD, Kappil M, Ferris JS, Liao Y, et al. Global methylation profiles in DNA from different blood cell types. Epigenetics 2011; 6:76-85; PMID:20890131; http://dx.doi.org/10.4161/ epi.6.1.13391
60. Hinton DM, Myers MJ, Raybourne RA, Francke-Carroll S, Sotomayor RE, Shaddock J, et al. Immunotoxicity of aflatoxin B1 in rats: effects on lymphocytes and the inflammatory response in a chronic intermittent dosing study. Toxicol Sci 2003; 73:362-77; PMID:12700391; http://dx.doi.org/10.1093/toxsci/ kfg074
61. Hatch MC, Chen CJ, Levin B, Ji BT, Yang GY, Hsu SW, et al. Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan. Int J Cancer 1993; 54:931-4; PMID:8392983; http:// dx.doi.org/10.1002/ijc.2910540611
62. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33:6823-36; PMID:16326863; http://dx.doi. org/10.1093/nar/gki987
63. Yang AS, Estécio MRH, Doshi K, Kondo Y, Tajara EH, Issa JPJ. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:e38; PMID:14973332; http://dx.doi.org/10.1093/nar/ gnh032